Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial.

Author: Verma, Subodh MD, PhD; Bhatt, Deepak L. MD, MPH; Bain, Stephen C. MD; Buse, John B. MD, PhD; Mann, Johannes F.E. MD; Marso, Steven P. MD; Nauck, Michael A. MD; Poulter, Neil R. FMedSci; Pratley, Richard E. MD; Zinman, Bernard MD; Michelsen, Marie M. MD; Monk Fries, Tea MD, PhD; Rasmussen, Soren MSc, PhD; Leiter, Lawrence A. MD; the LEADER Publication Committee on behalf of the LEADER Trial Investigators

Page: 2179-2183

https://ift.tt/2KpkA8q